Reported Adverse Effects Reported adverse effects from online forums cited in a 2025 systematic review (PMC12313605) included: Anxiety and panic attacks Depression and anhedonia Insomnia Heart palpitations Fatigue and weakness Loss of appetite These anecdotal reports cannot be verified as directly caused by BPC-157 versus contamination, incorrect dosing, or concurrent conditions, but they raise concerns that the peptide might paradoxically worsen mental health in some individuals
Argentyn 23 1/2 1 tsp daily Nystatin tabs or liquid 500,000 units 1/4 to 1/2 tsp or tab daily, increasing to 1 tsp or tab 4x/day (if gliotoxin or candida present) Itraconazole (Sporanox) 100mg every week or two, increasing to daily or even 1-2 tabs 2x/day Fluconazole (Diflucan) 100mg every week or two, increasing to daily or even 2x/day N-acetyl-cysteine 500mg 1-2 caps 2x/day (especially with Gliotoxins from Aspergillus or Candida) Special considerations Very sensitive or toxic patients may need pretreatment prior to using the above measures
Severe hypoglycaemia (blood glucose below 40 mg/dL or 2.2 mmol/L) can produce seizures and loss of consciousness
SURMOUNT-5 stands alone as the only large-scale, head-to-head phase trial directly comparing tirzepatide and semaglutide for obesity under identical conditions
However, snacking frequency should be flexiblesome days you may need 2 snacks, other days none
The body makes enough GLP-1, PYY and GIP to handle the job
